Yoder JM, Brandeland M, Engeland WC. Phase-dependent resetting of the adrenal clock by ACTH in vitro. Am J Physiol Regul Integr Comp Physiol 306: R387-R393, 2014. First published January 29, 2014 doi:10.1152/ajpregu.00519.2013The adrenal cortex has a molecular clock that generates circadian rhythms in glucocorticoids, yet how the clock is synchronized to the external environment is unknown. Using mPER2::Luciferase (mPER2Luc) knockin mice, in which luciferase is rhythmically expressed under the control of the mouse Per2 clock gene, we hypothesized that ACTH transmits entrainment signals to the adrenal. Adrenal explants were administered ACTH at different phases of the mPER2Luc rhythm. Treatment with ACTH 1-39 produced a phase delay that was phase-dependent, with a maximum at circadian time (CT)18; ACTH did not alter the period or amplitude of the rhythm. Forskolin produced a parallel response, suggesting that the phase delay was cAMP-mediated. The response to ACTH was concentration-dependent and peptide-specific. Pulse administration (60 min) of ACTH 1-39 also produced phase delays restricted to late CTs. In contrast to ACTH 1-39, other ACTH fragments, including ␣-melanocyte-stimulating hormone, which do not activate the melanocortin 2 (MC2/ACTH) receptor, had no effect. The finding that ACTH in vitro phase delays the adrenal mPER2luc rhythm in a monophasic fashion argues for ACTH as a key resetter, but not the sole entrainer, of the adrenal clock. adrenal clock; adrenocorticotropic hormone; nonphotic entrainment THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) axis is characterized by a robust circadian variation in glucocorticoids. This rhythm is paralleled by rhythms in plasma ACTH (6), and adrenal sensitivity to ACTH (10) mediated, in part, by sympathetic activity (49). Rhythmic ACTH secretion is regulated by corticotropin-releasing hormone (CRH) from the hypothalamic paraventricular nucleus (PVN) (6). Circadian timing is dependent on a clock in the suprachiasmatic nucleus (SCN) (41) that is reset daily by photic information transmitted from the retina (28) with SCN neurons relaying these signals to the PVN (19). This mechanism guarantees that glucocorticoid rhythms are entrained to the daily light-dark (LD) cycle.
adrenal clock; adrenocorticotropic hormone; nonphotic entrainment THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) axis is characterized by a robust circadian variation in glucocorticoids. This rhythm is paralleled by rhythms in plasma ACTH (6) , and adrenal sensitivity to ACTH (10) mediated, in part, by sympathetic activity (49) . Rhythmic ACTH secretion is regulated by corticotropin-releasing hormone (CRH) from the hypothalamic paraventricular nucleus (PVN) (6) . Circadian timing is dependent on a clock in the suprachiasmatic nucleus (SCN) (41) that is reset daily by photic information transmitted from the retina (28) with SCN neurons relaying these signals to the PVN (19) . This mechanism guarantees that glucocorticoid rhythms are entrained to the daily light-dark (LD) cycle.
A molecular clock exists in the SCN (39) and peripheral tissues (12) , including the adrenal (4) . The clock consists of interlocking feedback loops of gene transcription and translation (39) . The "positive" limb involves CLOCK and BMAL1, which heterodimerize and activate transcription of period genes, Per1 and Per2, and cryptochrome genes, Cry1 and Cry2. The Per and Cry transcripts increase with the protein products, PER and CRY, functioning as the "negative limb" by forming heterodimers that act on the CLOCK:BMAL1 complex to repress their own transcription. The feedback loops are self-regulating with an ϳ24-h periodicity.
The adrenal clock controls steroidogenesis by gating sensitivity to ACTH. In Per2/Cry1 mutant mice that lack a functioning clock, rhythms in adrenal sensitivity are absent and the corticoid rhythm is blunted (35) . The steroidogenic acute regulatory protein (StAR) participates in the gating mechanism, as it is required for steroidogenesis (18) , displays a circadian rhythm (16) and is activated by CLOCK:BMAL1 (47) . When the adrenal clock is knocked down by expressing antisense to BMAL1 using the ACTH (melanocortin 2) receptor (MC2R) promoter, the MC2R-AS-BMAL mice show no corticoid rhythm in constant dark, indicating that the adrenal clock drives the free-running rhythm (47) . Since SCN lesions abolish corticoid rhythmicity, SCN-dependent outputs are required to synchronize the adrenal clock and the resultant glucocorticoid rhythms to LD cycles (29) . We hypothesize that ACTH and sympathetic neural activity are SCN-dependent outputs that mediate corticoid rhythms via LD entrainment of an autonomous adrenal clock.
To assess whether ACTH entrains the adrenal clock, we used adrenals from mPER2::Luciferase (mPER2Luc) knockin mice (53) . This approach allows us to test direct responses of the adrenal clock to potential entraining signals in vitro, as shown for other peripheral clocks (31, 40) . If entrainment occurs, the phase of the PER2Luc rhythm should shift in response to ACTH in a phase-dependent fashion.
MATERIALS AND METHODS
Animals. Homozygous male mPER2::Luc mice (2-5 mo old) bred in-house were housed on a 12:12 LD cycle (lights on at 0600). Animals were maintained and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Experimental procedures were approved by the University of Minnesota Animal Care and Use Committee.
Bioluminescence. Animals were killed by CO 2 asphyxiation 3.5-4.0 h before lights out [at Zeitgeber time (ZT) 8 -8.5 ]. Adrenals were rapidly excised and placed in cold Hank's balanced salt solution. Cleaned and hemisected adrenals were placed on Millicell organotypic inserts in a 35-mm Petri dish with 1.5 ml of warmed culture media (DMEM, high glucose w/o Phenol Red) supplemented with luciferin and penicillin/streptomycin, as described by others (53) . Dishes were sealed with circular glass coverslips and silicon grease. Cultures were maintained at 36°C, and bioluminescence was measured using photomultiplier tubes (PMT) in an Actimetrics Lumicycle.
Assessing mPER2Luc rhythms. Tissue was treated at the circadian time (CT) indicated by replacement with fresh media containing rat ACTH 1-39 (Bachem), forskolin (BioMol International), human ␣-melanocyte-stimulating hormone (␣-MSH; Bachem), human ACTH 7-38 (Phoenix Pharmaceuticals), ACTH 11-24 (Bachem), vasoactive intestinal polypeptide (VIP; Bachem), CRH (Bachem), or vehicle (fresh media alone). Pulse experiments consisted of treatment at the specified CT followed by replacement with untreated fresh media after 60 min.
Data analysis. Lumicycle data were smoothed and detrended using a 2-h and 24-h running average, then baseline subtracted, and the pretreatment rhythm was fit to a damped sine wave using Lumicycle Analysis software (Actimetrics). The pretreatment period was calculated from at least 50 h of data beginning ϳ35 h after the onset of tissue incubation to reduce the transient effects of tissue preparation, as described by others (11) . The posttreatment period was calculated using at least 50 h of recording beginning 15 h after treatment, the point at which the error introduced by opening the PMT chamber no longer affected analysis. Period changes were calculated for each explant relative to its pretreatment period and expressed as hours lengthened (positive values) or shortened (negative values). To assess phase shifts, the "predicted" posttreatment peak phase was extrapolated using the damped sine wave fit to the pretreatment rhythm, and compared with the "observed" posttreatment peak phase, defined as that occurring 12 to 36 h after treatment. Phase shifts are expressed as hours advanced (positive values) or delayed (negative values). Amplitude changes are expressed relative to pretreatment peak height [calculated as ϫ100 (posttreatment bioluminescence peak-trough/ pretreatment peak-trough)], as described by others (34) . Only explants showing rhythms with a goodness of fit Ͼ85% for the pretreatment and posttreatment conditions were accepted.
Statistical analysis. Data are presented as means Ϯ SE. Statistical differences were determined using one-way ANOVA (using Tukey's or Dunnett's correction for post hoc analysis), or two-way ANOVA (using Tukey's correction for post hoc analysis) where appropriate using Prism software (GraphPad). Differences were considered significant if P Ͻ 0.05.
RESULTS

Unstimulated mPER2Luc adrenals.
Rhythms from left and right hemiadrenals were compared under baseline conditions. Since there were no differences in period or peak phase between hemiadrenals prior to treatment (Table 1) , hemiadrenals were assigned randomly to treatment conditions. Following pretreatment data collection, adrenal explant cultures were replaced with fresh media (vehicle) or media containing ACTH or other treatments. Absolute (Fig. 1A) and detrended (Fig. 1B ) bioluminescence for multiple adrenals is shown for a representative experiment consisting of vehicle treatment. Although amplitude dampening occurred over days in culture, the period of the rhythm for the entire duration of the experiment (22.8 Ϯ 0.1) did not differ from the period calculated for pretreatment (22.5 Ϯ 0.1) and posttreatment (22.8 Ϯ 0.2).
Responses to ACTH. To establish whether there was a phase-dependent response, ACTH was administered at CT2, CT6, CT10, CT14, CT18, and CT22. Absolute ( Fig. 1C) and detrended ( Fig. 1D ) bioluminescence for multiple adrenals is shown for an experiment measuring the response to 10 nM ACTH administered at CT18. There were no differences in the period or amplitude of the rhythm between the pretreatment and posttreatment conditions (see Table 2 ). Following ACTH treatment, the peak phase of the mPER2Luc rhythm occurred at ϳ118 h (Fig. 1D) ; the phase was delayed compared with the peak phase following vehicle treatment (shown in Fig. 1B ) of ϳ110 h.
The pretreatment peak phase and period of the mPER2Luc rhythm did not differ across treatment groups at any CT ( Table  2 ). Treatment with ACTH 1-39 (10 and 100 nM) produced a phase delay in the mPer2::Luc rhythm in a phase-dependent fashion with differences from vehicle at CT10, CT14, CT18, and CT22 (only 10.0 nM tested), but no response at CT2 or CT6. The response to forskolin (20.0 M) paralleled that of ACTH, producing a phase delay only at CT10, CT14, and CT18 (Fig. 2) . There was no effect of ACTH or forskolin on the period or amplitude of the rhythm, except a change in period at CT2 ( Table 2 ). The response to ACTH 1-39 at CT18 was concentration-dependent with a minimum effective concentration of 1.0 nM compared with vehicle (Fig. 3A) ; there was no concentration-dependent change in period or amplitude following ACTH (data not shown). To assess peptide specificity, equimolar concentrations (10.0 nM) of ACTH 1-39 were compared with VIP 1-28 and CRH 1-41 at CT18. Results confirmed the phase delay produced by ACTH, but neither CRH nor VIP produced a similar response (Fig. 3B ). Changes in period were not observed in response to ACTH, CRH, or VIP (data not shown). These results show a phase-dependent delay in the mPER2Luc rhythm following treatment with ACTH 1-39; treatments were given at different CTs without washout to avoid potential changes in bioluminescence produced by changing the media as noted by others (54) . To confirm the phase-dependent response to ACTH, pulses of ACTH 1-39 (1.0 nM) were administered at different CTs by replacement with fresh media after 1 h of incubation. The pretreatment peak phase and period of the mPER2Luc rhythm did not differ between treatment groups at any CT (Table 3) . Compared with vehicle, ACTH pulses produced only a phase delay that was restricted to CT18 (Fig. 4) . To confirm that the response to ACTH was independent of time in culture, adrenal tissue was given an ACTH pulse at CT22 of the preceding cycle [CT(-2)]. The response to ACTH at CT(-2) also was a phase delay, supporting the conclusion that ACTH produces a phase shift that is dependent on the phase of the rhythm not time in culture (Fig. 4) . There was no effect of ACTH 1-39 pulses at any CT on the period of the mPER2Luc rhythm (Table 3) .
Finally, to examine whether the response is dependent on the ACTH receptor, pulses of ACTH 1-39 were given in the presence and absence of ACTH fragments that bind the MC2R but do not activate a steroidogenic response (21, 24) . Whereas pulses of ACTH 1-39 (1.0 nM) produced a phase delay at CT18, there was no response to high concentrations of either ACTH 7-38 (10.0 M) or ACTH 11-24 (0.1 M) (Fig. 5, A  and B) . Coadministration did not affect the response to ACTH 1-39, showing that neither ACTH 11-24 nor ACTH 7-38 acts as an inhibitor of ACTH 1-39 under these culture conditions ( Fig. 5, A and B) . Since adrenal expression of the MC5R has been reported (17) , it is possible that the ACTH response is mediated by the MC5R. However, neither 1 nM nor 10 nM ␣-MSH produced a phase delay compared with 1 nM ACTH 1-39 (Fig. 5C ). Together, these results support the selectivity of the ACTH 1-39 peptide, suggesting that the ACTH-induced phase delay requires activation of the MC2 receptor.
DISCUSSION
Using adrenal explants from mPER2Luc mice, we found that ACTH produces a phase delay in the mPER2Luc rhythm that is phase-dependent, concentration-dependent, peptide-specific, and ACTH 1-39-selective. The monophasic nature of the ACTH response eliminates the possibility that it is the sole mechanism for entraining the adrenal clock to a LD cycle. However, these data support the possibility that ACTH induced by stress could reset the adrenal clock in a phase-dependent fashion.
The adrenal cortex expresses a clock that generates a circadian rhythm in glucocorticoids by inducing StAR, a clockcontrolled gene, in a cyclical fashion (47) . Although this clock is sufficient to elicit rhythmic steroidogenesis independently of environmental cues, it requires extrinsic input for entrainment to environmental stimuli. The circadian glucocorticoid rhythm is dependent on the SCN (38) that is entrained by LD transitions. By constructing a phase-response curve (PRC), we tested the hypothesis that ACTH mediates photic entrainment of the adrenal clock, defined by a phase delay followed by a phase advance (15) . Although the adrenal cannot respond directly to light, the term "photic entrainment" is used to refer to the process by which extrinsic signals to the adrenal convey light-dark information from the SCN to entrain adrenal rhythms. Our results showed that ACTH produced a phase delay only, suggesting that ACTH alone does not mediate photic entrainment. The circadian rhythm in ACTH shows a low amplitude (twofold) relative to that of corticosterone (10-fold), requiring a rhythm in adrenal sensitivity to amplify the ACTH signal (10) . Sympathetic denervation reduces adrenal sensitivity, which is evidence for adrenal innervation as an underlying mechanism (49) . Since rhythms in sympathetic activity are driven by SCN-dependent pathways (5) and neural input stimulates adrenal Per expression (20) , sympathetic input in concert with rhythmic ACTH could mediate photic entrainment of the adrenal clock. Adrenocortical innervation includes VIPergic fibers (23) . Because corticosterone rhythms are suppressed in constitutive VIP knockout (26, 27) and VIP receptor knockout mice (13, 45) , ACTH could complement VIPergic innervation to mediate photic entrainment of the adrenal clock.
The PRC using adrenal explants showed that treatment with ACTH at 4-h intervals produced a phase delay with a peak response at CT18. Neither the period nor the amplitude of the rhythm was affected by ACTH. The magnitude of the phase shift at CT18 was concentration-dependent and peptide-specific; responses were not observed following CRH 1-41 or VIP 1-28, peptides that bind receptors in the adrenal cortex to elicit steroid responses (32, 50) . Because ACTH is degraded within 2 h in adrenal tissue culture (3), treatment at CTs separated by 4 h should provide "pulse-like" exposure to ACTH; however, the resolution of the PRC could be masked by lingering bioactivity. To more precisely define the phase shift, the PRC was reexamined using 60-min pulses of ACTH, yielding a similar curve with a significant delay limited to CT18. Pulses of ACTH at CT(-2), corresponding to CT22 of the previous cycle, also produced a phase delay. These data show that ACTH produces a phase delay in late CTs that is dependent on the phase of the rhythm and not the duration of explant culture.
Multiple approaches were used to determine whether ACTH was acting via the MC2R to phase shift the adrenal clock. Since the MC2R is a G s protein-coupled receptor linked to activation of adenylyl cyclase and cAMP generation (9, 43) , clock entrainment by ACTH may be cAMP-dependent. It is well established that cAMP is involved in resetting the SCN and peripheral clocks (33, 34, 37, 48) . Forskolin, an activator of adenylyl cyclase, produced a PRC similar to that of ACTH. In contrast, neither VIP nor CRH elicited a phase shift when administered at CT18, although both affect adrenal steroidogenesis via G s protein-coupled receptors (32, 50) . A more thorough examination of these peptides is warranted, yet these findings further support the specificity of MC2R activation by ACTH in resetting the adrenal clock. Putative MC2R antagonists also were tested. Both and bind to the MC2R but show low potency relative to ACTH 1-39 in activating a steroidogenic response. Neither pulses of ACTH 7-38 nor ACTH 11-24 produced phase shifts, supporting the specificity of ACTH 1-39 in eliciting a response. However, neither peptide altered the response when coadministered with ACTH 1-39. As shown for other G proteincoupled receptors (1), multiple binding sites on the MC2R have been postulated that differentially affect agonist and antagonist activity (21) . Under the required experimental conditions of 3-4 days for explant culture, it is possible that antagonist affinity for the MC2R is reduced for these ACTH fragments, rendering them ineffective. In addition to the MC2R, the rodent adrenal cortex expresses the MC5R (51), a receptor that can be activated by ACTH 1-39; in contrast, the MC1, MC3, and MC4 receptors have not been identified in the adrenal cortex (7). Since ␣-MSH is a more potent ligand for the MC5R compared with ACTH (14) and ␣-MSH does not activate the MC2R (30) , ␣-MSH was tested. We found that ␣-MSH produced no phase shift, suggesting that the response to ACTH is not MC5R-mediated. Although the absence of MC2R blockade is a limitation, the selectivity of ACTH 1-39 argues strongly for MC2R dependency in the phase shift of the adrenal clock rhythm.
The mechanism for a phase-dependent response of the adrenal clock rhythm to ACTH is unclear. Since high concentrations of ACTH administered at early CTs were ineffective in phase shifting the mPER2Luc rhythm, it is likely that adrenal clock sensitivity to ACTH varies in a cyclical fashion, as shown for the steroidogenic responses to ACTH (10, 42) . Similar to light-induced phase shifts of the SCN clock (52) , phase resetting of the adrenal clock may result from ACTHinduced increases in adrenal PER that vary with the time of stimulation to differentially change PER negative feedback on the molecular clock. Additional studies are warranted to assess this possibility.
Perspectives and Significance
The novel finding that ACTH shifted the phase of the mPER2Luc rhythm in a monophasic fashion at a concentration in the high physiological range (0.1 nM) suggests that stressinduced ACTH might be capable of resetting the adrenal clock in vivo. The adrenal clock drives the rhythm in circulating glucocorticoids (35, 47) . Thus, stress-induced increases in ACTH and subsequent resetting of the adrenal clock phase likely would shift the phase of the glucocorticoid rhythm. Since rhythmic glucocorticoids are critical for maintaining homeostasis by controlling glucose metabolism (46) , entrainment of other peripheral clocks (2, 22, 36) and regulating clock gene rhythms in brain nuclei implicated in control of motivation and emotional states (44) , acute stress could have persistent deleterious effects on organ system function by altering the timing of glucocorticoid-dependent rhythms. Since the disruption of circadian rhythms in glucocorticoids is associated with multiple somatic and psychiatric disorders (8) , understanding the mechanisms for ACTH-induced resetting of the adrenal clock rhythm could facilitate the development of optimal treatment strategies.
